Traditional Chinese Pharmacological Laboratory, Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
Chin J Integr Med. 2020 Jul;26(7):552-559. doi: 10.1007/s11655-020-3256-7. Epub 2020 Apr 1.
Lipopolysaccharide (LPS)-induced inflammation causes massive threatening diseases, such as sepsis, acute lung injury and multiple organ dysfunction syndrome. Efficient treatment to prevent inflammation is crucial in LPS-induced inflammatory diseases. Heat-clearing Chinese medicines (CMs) have been used to ameliorate LPS-induced inflammation in China for centuries. Heat-clearing CMs regulate inflammatory pathways, thereby inhibiting the release of inflammatory factors. This review aimed to introduce promising heat-clearing CMs countering LPS-induced inflammation in the last 5 years, exploring the underlying molecular mechanisms.
脂多糖(LPS)诱导的炎症会引发严重的威胁生命的疾病,如败血症、急性肺损伤和多器官功能障碍综合征。因此,寻找有效治疗方法以预防炎症在 LPS 诱导的炎症性疾病中至关重要。清热中药(CMs)在中国已被用于缓解 LPS 诱导的炎症已有数百年的历史。清热中药通过调节炎症途径,从而抑制炎症因子的释放来发挥抗炎作用。本综述旨在介绍近 5 年来具有潜力的对抗 LPS 诱导的炎症的清热中药,并探讨其潜在的分子机制。